Characterization of the Analgesic Effects of Oral CBD in Healthy, Normal Volunteers

Trial Profile

Characterization of the Analgesic Effects of Oral CBD in Healthy, Normal Volunteers

Active, no longer recruiting
Phase of Trial: Phase I/II

Latest Information Update: 12 Apr 2018

At a glance

  • Drugs Cannabidiol (Primary)
  • Indications Dravet syndrome; Drug abuse; Epilepsy; Glioblastoma; Infantile spasms; Lennox-Gastaut syndrome; Peripheral nervous system diseases
  • Focus Therapeutic Use
  • Most Recent Events

    • 09 Apr 2018 Planned primary completion date changed from 1 Dec 2017 to 1 Dec 2018.
    • 10 Aug 2017 Status changed from recruiting to active, no longer recruiting.
    • 20 Sep 2016 Status changed from not yet recruiting to recruiting.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top